212 related articles for article (PubMed ID: 3030162)
1. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Manrique RV; Manrique V
Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
[TBL] [Abstract][Full Text] [Related]
2. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
Weithmann KU
Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
[TBL] [Abstract][Full Text] [Related]
3. Drug stimulated prostacyclin release.
Weithmann KU
Ric Clin Lab; 1981; 11 Suppl 1():209-14. PubMed ID: 6324324
[TBL] [Abstract][Full Text] [Related]
4. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
5. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
Weithmann KU; Just M; Schlotte V; Seiffge D
Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
[TBL] [Abstract][Full Text] [Related]
7. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
Matzky R; Darius H; Schrör K
Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
11. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
Buttrick PM; Forscher CA; Sussman II; Mueller HS
Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
[TBL] [Abstract][Full Text] [Related]
12. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
13. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
Vanderwel M; Haslam RJ
J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
[TBL] [Abstract][Full Text] [Related]
15. [Pentoxifylline and prostaglandins].
Poggesi L; Boddi M; Scarti L; Masotti G
Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
[No Abstract] [Full Text] [Related]
16. [Influence of high-voltage electrical burn on the rheological property of platelet and leukocyte in rats and the interventional effect of pentoxifylline].
Zhang QF; Wei W; Shang T; Zhou HM; Li ZN; Wang CJ; Feng JK; Xu SJ; Cui DS
Zhonghua Shao Shang Za Zhi; 2012 Dec; 28(6):428-34. PubMed ID: 23327912
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
19. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
20. Influence of pentoxifylline administered in vivo on the synthesis of PGI2 in human varicose veins.
Fahr A; Langer R; Sziegoleit W; Albert H; Liebal H; Mest HJ
Biomed Biochim Acta; 1988; 47(10-11):S238-40. PubMed ID: 3073763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
